Back to RXRX
Wedmont Private Capital → RXRX
Wedmont Private Capital RXRX Position History
Recursion Pharmaceuticals, Inc.
Quarters held
4
Latest value
$75K
Q3 2026
Peak value
$92K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $92K |
| Q1 2026 | $64K |
| Q2 2026 | $67K |
| Q3 2026 | $75K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $75K | 18.9K | — | — |
| Q2 2026 | $67K | 18.9K | — | — |
| Q1 2026 | $64K | 18.9K | — | — |
| Q4 2025 | $92K | 18.9K | — | — |